| Hannah Johnson, PA-C | |
|
4359 New Shepherdsville Rd Unit 245, Bardstown, KY 40004-8004 | |
| (502) 350-5492 | |
| (502) 350-5822 |
| Full Name | Hannah Johnson |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 9 Years |
| Location | 4359 New Shepherdsville Rd Unit 245, Bardstown, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1427429620 | NPI | - | NPPES |
| 7100386810 | Medicaid | KY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363AS0400X | Physician Assistant - Surgical | TC438 (Kentucky) | Secondary |
| 363AS0400X | Physician Assistant - Surgical | PA2044 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Baptist Health Louisville | Louisville, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Baptist Health Medical Group Inc | 5597867184 | 1912 |
News Archive
Nabi Biopharmaceuticals announced that it has initiated the second of two pivotal Phase III clinical trials for NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary vaccine to treat nicotine addiction and prevent smoking relapse. The FDA has agreed with Nabi on the study design, protocol and end points through a Special Protocol Assessment (SPA). The SPA forms a basic foundation to support approval of a New Drug Application. The Company also received scientific advice from the European Medicines Agency (EMEA) that confirms and supports the trial protocol.
It was Saturday morning at Southbay Tattoo and Body Piercing in Carson, California, and owner Efrain Espinoza Diaz Jr. was prepping for his first tattoo of the day — a memorial portrait of a man that his widow wanted on her forearm.
A new study in the January 7th issue of Cell Metabolism , a Cell Press publication, helps to explain why obese people and animals fail to respond to leptin, a hormone produced by fat that signals the brain to stop eating.
Advaxis, Inc., (OTCQB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus (HPV)-associated anal cancer.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Hannah Johnson, PA-C Po Box 936, London, KY 40743-0936 Ph: (606) 330-7835 | Hannah Johnson, PA-C 4359 New Shepherdsville Rd Unit 245, Bardstown, KY 40004-8004 Ph: (502) 350-5492 |
News Archive
Nabi Biopharmaceuticals announced that it has initiated the second of two pivotal Phase III clinical trials for NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary vaccine to treat nicotine addiction and prevent smoking relapse. The FDA has agreed with Nabi on the study design, protocol and end points through a Special Protocol Assessment (SPA). The SPA forms a basic foundation to support approval of a New Drug Application. The Company also received scientific advice from the European Medicines Agency (EMEA) that confirms and supports the trial protocol.
It was Saturday morning at Southbay Tattoo and Body Piercing in Carson, California, and owner Efrain Espinoza Diaz Jr. was prepping for his first tattoo of the day — a memorial portrait of a man that his widow wanted on her forearm.
A new study in the January 7th issue of Cell Metabolism , a Cell Press publication, helps to explain why obese people and animals fail to respond to leptin, a hormone produced by fat that signals the brain to stop eating.
Advaxis, Inc., (OTCQB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus (HPV)-associated anal cancer.
› Verified 3 days ago
Lara L Wood, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 4359 New Shepherdsville Rd, Bardstown, KY 40004 Phone: 859-278-1316 Fax: 859-276-3847 | |
Mr. Timothy M West, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 875 Pennsylvania Ave, Bardstown, KY 40004 Phone: 502-348-5685 Fax: 502-348-1771 | |
Zeth Thomas Rogers, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1013 Granite Dr, Bardstown, KY 40004 Phone: 502-349-3100 Fax: 502-349-3169 | |
David Gerard Demar Sr., CSFA/KCSA Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 4305 New Shepherdsville Rd, Bardstown, KY 40004 Phone: 502-350-5521 | |
Andrea Hale Stucker, P.A.-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 875 Pennsylvania Ave, Bardstown, KY 40004 Phone: 502-348-5685 Fax: 502-348-1771 | |
Nancy Mae Hale, P.A. Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 118 Patriot Dr, Suite 102, Bardstown, KY 40004 Phone: 502-350-1022 Fax: 502-350-1023 |